Stacie Hudgens Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

11/2023

Establishing Meaningful Change Thresholds in Patient-Reported Outcomes Among Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in ALTA-1L Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stacie Hudgens Research Topics

Disease

7	Neoplasms (Cancer) 02/2024 - 08/2003
5	Disease Progression 06/2021 - 09/2002
4	Pain (Aches) 10/2021 - 12/2018
3	Primary Myelofibrosis (Myelosclerosis) 02/2024 - 04/2014
3	Nausea 01/2018 - 12/2015
2	Treatment-Resistant Depressive Disorder 01/2022 - 01/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2021 - 08/2003
2	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 06/2021 - 11/2020
2	Eosinophilic Esophagitis 01/2021 - 01/2017
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2021 - 01/2018
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 01/2017
2	Deglutition Disorders (Dysphagia) 01/2021 - 01/2017
2	Carcinoid Tumor (Carcinoid) 10/2019 - 12/2018
2	Vomiting 01/2017 - 12/2015
2	Carcinoma (Carcinomatosis) 08/2003 - 09/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023
1	Constipation 11/2023
1	Polyuria 06/2022
1	Nocturia 06/2022
1	Psoriatic Arthritis 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Multiple Myeloma 10/2021
1	Symptom Flare Up 01/2021
1	Fatigue 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020
1	Hidradenitis Suppurativa 12/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2018
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Prostatic Neoplasms (Prostate Cancer) 10/2018
1	Polymyositis 01/2018
1	Cellulitis 01/2018
1	Fever (Fevers) 01/2018
1	Hepatitis C 01/2018
1	Mycosis Fungoides 01/2018
1	Neutropenia 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Pulmonary Embolism 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Bronchopneumonia 01/2018
1	Intermediate Uveitis (Chronic Cyclitis) 01/2017
1	Panuveitis 01/2017
1	Posterior Uveitis 01/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Diarrhea 12/2015
1	Headache (Headaches) 12/2015
1	Alopecia (Baldness) 12/2015
1	Breast Neoplasms (Breast Cancer) 12/2015
1	Anemia 04/2014

Drug/Important Bio-Agent (IBA)

2	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 02/2024 - 01/2023
2	Nasal SpraysIBA 01/2022 - 01/2021
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2021
2	EsketamineIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 06/2021 - 11/2020
2	Monoclonal AntibodiesIBA 01/2021 - 01/2018
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2021 - 01/2017
2	mogamulizumabIBA 01/2021 - 01/2018
2	SuspensionsIBA 01/2021 - 01/2017
2	Vorinostat FDA Link 01/2021 - 01/2018
2	telotristat ethylIBA 10/2019 - 12/2018
2	Adalimumab (Humira)FDA Link 12/2018 - 01/2017
2	PlatinumIBA 01/2018 - 09/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 04/2014
2	Carboplatin (JM8)FDA LinkGeneric 08/2003 - 09/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2003 - 09/2002
1	Syntex adjuvant formulationIBA 02/2024
1	brigatinibIBA 11/2023
1	CrizotinibIBA 11/2023
1	Anaplastic Lymphoma KinaseIBA 11/2023
1	Prostaglandins AIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021
1	selinexorIBA 10/2021
1	Bortezomib (Velcade)FDA Link 10/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	lenvatinibIBA 01/2021
1	Zolpidem (Ambien)FDA LinkGeneric 01/2021
1	LipidsIBA 11/2020
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2018
1	AndrogensIBA 10/2018
1	apalutamideIBA 10/2018
1	vasectrin IIIIBA 01/2018
1	ombitasvirIBA 01/2018
1	paritaprevirIBA 01/2018
1	niraparibIBA 01/2018
1	CC ChemokinesIBA 01/2018
1	AT 61IBA 01/2018
1	Dacarbazine (DIC)FDA LinkGeneric 01/2017
1	Rituximab (Mabthera)FDA Link 01/2016
1	eribulin FDA Link 12/2015
1	Capecitabine (Xeloda)FDA Link 12/2015
1	Prednisone (Sone)FDA LinkGeneric 04/2014
1	pomalidomideIBA 04/2014

Therapy/Procedure

9	Therapeutics 01/2021 - 08/2003
3	Drug Therapy (Chemotherapy) 01/2018 - 09/2002
1	Ambulatory Care (Outpatient Care) 06/2022
1	Castration 10/2018
1	Long-Term Care 01/2017
1	Erythrocyte Transfusion 04/2014